Report cover image

Global Typhoid Vaccine Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Jul 16, 2025
Length 193 Pages
SKU # APRC20284047

Description

Summary

According to APO Research, The global Typhoid Vaccine market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Typhoid Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Typhoid Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Typhoid Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Typhoid Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Typhoid Vaccine include Actiza Pharmaceutical, Bharat Biotec, Merit Pharmaceuticals, PaxVax, GlaxoSmithKline, Merck and Sanofi, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Typhoid Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Typhoid Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Typhoid Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Typhoid Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Typhoid Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Typhoid Vaccine sales, projected growth trends, production technology, application and end-user industry.

Typhoid Vaccine Segment by Company

Actiza Pharmaceutical
Bharat Biotec
Merit Pharmaceuticals
PaxVax
GlaxoSmithKline
Merck
Sanofi
Typhoid Vaccine Segment by Type

Oral Type Typhoid Vaccine
Injection Type Typhoid Vaccine
Typhoid Vaccine Segment by Application

Pharmaceutical & Biotechnology Companies
Hospital
Research & Academic Laboratories
Others
Typhoid Vaccine Segment by Region

North America
United States
Canada
Europe

Germany
France
U.K.
Italy
Netherlands
Asia-Pacific

China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America

Mexico
Brazil
Argentina
Middle East & Africa

Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Typhoid Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Typhoid Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Typhoid Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Typhoid Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Typhoid Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Typhoid Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

193 Pages
1 Market Overview
1.1 Product Definition
1.2 Typhoid Vaccine Market by Type
1.2.1 Global Typhoid Vaccine Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Oral Type Typhoid Vaccine
1.2.3 Injection Type Typhoid Vaccine
1.3 Typhoid Vaccine Market by Application
1.3.1 Global Typhoid Vaccine Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Hospital
1.3.4 Research & Academic Laboratories
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Typhoid Vaccine Market Dynamics
2.1 Typhoid Vaccine Industry Trends
2.2 Typhoid Vaccine Industry Drivers
2.3 Typhoid Vaccine Industry Opportunities and Challenges
2.4 Typhoid Vaccine Industry Restraints
3 Global Market Growth Prospects
3.1 Global Typhoid Vaccine Revenue Estimates and Forecasts (2020-2031)
3.2 Global Typhoid Vaccine Revenue by Region
3.2.1 Global Typhoid Vaccine Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global Typhoid Vaccine Revenue by Region (2020-2025)
3.2.3 Global Typhoid Vaccine Revenue by Region (2026-2031)
3.2.4 Global Typhoid Vaccine Revenue Market Share by Region (2020-2031)
3.3 Global Typhoid Vaccine Sales Estimates and Forecasts 2020-2031
3.4 Global Typhoid Vaccine Sales by Region
3.4.1 Global Typhoid Vaccine Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global Typhoid Vaccine Sales by Region (2020-2025)
3.4.3 Global Typhoid Vaccine Sales by Region (2026-2031)
3.4.4 Global Typhoid Vaccine Sales Market Share by Region (2020-2031)
3.5 US & Canada & Mexico
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
4.1 Global Typhoid Vaccine Revenue by Manufacturers
4.1.1 Global Typhoid Vaccine Revenue by Manufacturers (2020-2025)
4.1.2 Global Typhoid Vaccine Revenue Market Share by Manufacturers (2020-2025)
4.1.3 Global Typhoid Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2024
4.2 Global Typhoid Vaccine Sales by Manufacturers
4.2.1 Global Typhoid Vaccine Sales by Manufacturers (2020-2025)
4.2.2 Global Typhoid Vaccine Sales Market Share by Manufacturers (2020-2025)
4.2.3 Global Typhoid Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2024
4.3 Global Typhoid Vaccine Sales Price by Manufacturers (2020-2025)
4.4 Global Typhoid Vaccine Key Manufacturers Ranking, 2023 VS 2024 VS 2025
4.5 Global Typhoid Vaccine Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Typhoid Vaccine Manufacturers, Product Type & Application
4.7 Global Typhoid Vaccine Manufacturers' Establishment Date
4.8 Market Competitive Analysis
4.8.1 Global Typhoid Vaccine Market CR5 and HHI
4.8.2 2024 Typhoid Vaccine Tier 1, Tier 2, and Tier 3
5 Typhoid Vaccine Market by Type
5.1 Global Typhoid Vaccine Revenue by Type
5.1.1 Global Typhoid Vaccine Revenue by Type (2020 VS 2024 VS 2031)
5.1.2 Global Typhoid Vaccine Revenue by Type (2020-2031) & (US$ Million)
5.1.3 Global Typhoid Vaccine Revenue Market Share by Type (2020-2031)
5.2 Global Typhoid Vaccine Sales by Type
5.2.1 Global Typhoid Vaccine Sales by Type (2020 VS 2024 VS 2031)
5.2.2 Global Typhoid Vaccine Sales by Type (2020-2031) & (K Units)
5.2.3 Global Typhoid Vaccine Sales Market Share by Type (2020-2031)
5.3 Global Typhoid Vaccine Price by Type
6 Typhoid Vaccine Market by Application
6.1 Global Typhoid Vaccine Revenue by Application
6.1.1 Global Typhoid Vaccine Revenue by Application (2020 VS 2024 VS 2031)
6.1.2 Global Typhoid Vaccine Revenue by Application (2020-2031) & (US$ Million)
6.1.3 Global Typhoid Vaccine Revenue Market Share by Application (2020-2031)
6.2 Global Typhoid Vaccine Sales by Application
6.2.1 Global Typhoid Vaccine Sales by Application (2020 VS 2024 VS 2031)
6.2.2 Global Typhoid Vaccine Sales by Application (2020-2031) & (K Units)
6.2.3 Global Typhoid Vaccine Sales Market Share by Application (2020-2031)
6.3 Global Typhoid Vaccine Price by Application
7 Company Profiles
7.1 Actiza Pharmaceutical
7.1.1 Actiza Pharmaceutical Comapny Information
7.1.2 Actiza Pharmaceutical Business Overview
7.1.3 Actiza Pharmaceutical Typhoid Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Actiza Pharmaceutical Typhoid Vaccine Product Portfolio
7.1.5 Actiza Pharmaceutical Recent Developments
7.2 Bharat Biotec
7.2.1 Bharat Biotec Comapny Information
7.2.2 Bharat Biotec Business Overview
7.2.3 Bharat Biotec Typhoid Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Bharat Biotec Typhoid Vaccine Product Portfolio
7.2.5 Bharat Biotec Recent Developments
7.3 Merit Pharmaceuticals
7.3.1 Merit Pharmaceuticals Comapny Information
7.3.2 Merit Pharmaceuticals Business Overview
7.3.3 Merit Pharmaceuticals Typhoid Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Merit Pharmaceuticals Typhoid Vaccine Product Portfolio
7.3.5 Merit Pharmaceuticals Recent Developments
7.4 PaxVax
7.4.1 PaxVax Comapny Information
7.4.2 PaxVax Business Overview
7.4.3 PaxVax Typhoid Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 PaxVax Typhoid Vaccine Product Portfolio
7.4.5 PaxVax Recent Developments
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Comapny Information
7.5.2 GlaxoSmithKline Business Overview
7.5.3 GlaxoSmithKline Typhoid Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 GlaxoSmithKline Typhoid Vaccine Product Portfolio
7.5.5 GlaxoSmithKline Recent Developments
7.6 Merck
7.6.1 Merck Comapny Information
7.6.2 Merck Business Overview
7.6.3 Merck Typhoid Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Merck Typhoid Vaccine Product Portfolio
7.6.5 Merck Recent Developments
7.7 Sanofi
7.7.1 Sanofi Comapny Information
7.7.2 Sanofi Business Overview
7.7.3 Sanofi Typhoid Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Sanofi Typhoid Vaccine Product Portfolio
7.7.5 Sanofi Recent Developments
8 North America
8.1 North America Typhoid Vaccine Market Size by Type
8.1.1 North America Typhoid Vaccine Revenue by Type (2020-2031)
8.1.2 North America Typhoid Vaccine Sales by Type (2020-2031)
8.1.3 North America Typhoid Vaccine Price by Type (2020-2031)
8.2 North America Typhoid Vaccine Market Size by Application
8.2.1 North America Typhoid Vaccine Revenue by Application (2020-2031)
8.2.2 North America Typhoid Vaccine Sales by Application (2020-2031)
8.2.3 North America Typhoid Vaccine Price by Application (2020-2031)
8.3 North America Typhoid Vaccine Market Size by Country
8.3.1 North America Typhoid Vaccine Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
8.3.2 North America Typhoid Vaccine Sales by Country (2020 VS 2024 VS 2031)
8.3.3 North America Typhoid Vaccine Price by Country (2020-2031)
8.3.4 United States
8.3.5 Canada
9 Europe
9.1 Europe Typhoid Vaccine Market Size by Type
9.1.1 Europe Typhoid Vaccine Revenue by Type (2020-2031)
9.1.2 Europe Typhoid Vaccine Sales by Type (2020-2031)
9.1.3 Europe Typhoid Vaccine Price by Type (2020-2031)
9.2 Europe Typhoid Vaccine Market Size by Application
9.2.1 Europe Typhoid Vaccine Revenue by Application (2020-2031)
9.2.2 Europe Typhoid Vaccine Sales by Application (2020-2031)
9.2.3 Europe Typhoid Vaccine Price by Application (2020-2031)
9.3 Europe Typhoid Vaccine Market Size by Country
9.3.1 Europe Typhoid Vaccine Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
9.3.2 Europe Typhoid Vaccine Sales by Country (2020 VS 2024 VS 2031)
9.3.3 Europe Typhoid Vaccine Price by Country (2020-2031)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Netherlands
10 China
10.1 China Typhoid Vaccine Market Size by Type
10.1.1 China Typhoid Vaccine Revenue by Type (2020-2031)
10.1.2 China Typhoid Vaccine Sales by Type (2020-2031)
10.1.3 China Typhoid Vaccine Price by Type (2020-2031)
10.2 China Typhoid Vaccine Market Size by Application
10.2.1 China Typhoid Vaccine Revenue by Application (2020-2031)
10.2.2 China Typhoid Vaccine Sales by Application (2020-2031)
10.2.3 China Typhoid Vaccine Price by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Typhoid Vaccine Market Size by Type
11.1.1 Asia Typhoid Vaccine Revenue by Type (2020-2031)
11.1.2 Asia Typhoid Vaccine Sales by Type (2020-2031)
11.1.3 Asia Typhoid Vaccine Price by Type (2020-2031)
11.2 Asia Typhoid Vaccine Market Size by Application
11.2.1 Asia Typhoid Vaccine Revenue by Application (2020-2031)
11.2.2 Asia Typhoid Vaccine Sales by Application (2020-2031)
11.2.3 Asia Typhoid Vaccine Price by Application (2020-2031)
11.3 Asia Typhoid Vaccine Market Size by Country
11.3.1 Asia Typhoid Vaccine Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
11.3.2 Asia Typhoid Vaccine Sales by Country (2020 VS 2024 VS 2031)
11.3.3 Asia Typhoid Vaccine Price by Country (2020-2031)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 Taiwan
11.3.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Typhoid Vaccine Market Size by Type
12.1.1 SAMEA Typhoid Vaccine Revenue by Type (2020-2031)
12.1.2 SAMEA Typhoid Vaccine Sales by Type (2020-2031)
12.1.3 SAMEA Typhoid Vaccine Price by Type (2020-2031)
12.2 SAMEA Typhoid Vaccine Market Size by Application
12.2.1 SAMEA Typhoid Vaccine Revenue by Application (2020-2031)
12.2.2 SAMEA Typhoid Vaccine Sales by Application (2020-2031)
12.2.3 SAMEA Typhoid Vaccine Price by Application (2020-2031)
12.3 SAMEA Typhoid Vaccine Market Size by Country
12.3.1 SAMEA Typhoid Vaccine Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
12.3.2 SAMEA Typhoid Vaccine Sales by Country (2020 VS 2024 VS 2031)
12.3.3 SAMEA Typhoid Vaccine Price by Country (2020-2031)
12.3.4 Brazil
12.3.5 Argentina
12.3.6 Chile
12.3.7 Colombia
12.3.8 Peru
12.3.9 Saudi Arabia
12.3.10 Israel
12.3.11 UAE
12.3.12 Turkey
12.3.13 Iran
12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
13.1 Typhoid Vaccine Value Chain Analysis
13.1.1 Typhoid Vaccine Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Typhoid Vaccine Production Mode & Process
13.2 Typhoid Vaccine Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Typhoid Vaccine Distributors
13.2.3 Typhoid Vaccine Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.